PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 0.9800
+0.0400 (4.26%)
At close: Feb 26, 2026
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 649.39 million as of February 25, 2026. Its market cap has decreased by -47.49% in one year.
Market Cap
649.39M
Enterprise Value
638.32M
Revenue
139.49M
Ranking
n/a
PE Ratio
66.80
Stock Price
0.98
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 649.39M, an increase of 1,862.67%. That is a compound annual growth rate of 11.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 649.39M | -23.58% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.11B |
| Anteris Technologies Global | 836.20M |
| Aroa Biosurgery | 226.29M |
| Lumos Diagnostics Holdings | 206.24M |
| EMVision Medical Devices | 163.57M |
| SomnoMed | 144.17M |
| Cleo Diagnostics | 82.12M |
| Compumedics | 66.42M |